论文部分内容阅读
目的:对保妇康栓联用重组人干扰素α-2b凝胶治疗宫颈炎合并HPV感染的临床效果进行分析。方法:选取65例宫颈炎合并HPV感染的患者随机分为实验组及对照组,其中,对照组(32例)单纯给予重组人干扰素α-2b凝胶进行治疗,实验组(33例)则在对照组治疗方法的基础上应用保妇康栓进行联合交替治疗,对比分析两组的临床指标。结果:对照组于治疗后,其HPV的转阴率明显比实验组低,且P<0.05,有统计学差异存在。结论:给予宫颈炎合并HPV感染的患者应用保妇康栓与重组人干扰素α-2b凝胶进行联合交替治疗,可取得较为显著的效果,建议推广。
Objective: To analyze the clinical effect of Baofukang suppository combined with recombinant human interferon α-2b gel in the treatment of cervicitis and HPV infection. Methods: Sixty-five patients with cervicitis complicated with HPV infection were randomly divided into experimental group and control group. The control group (32 cases) was treated with recombinant human interferon α-2b gel only. The experimental group (33 cases) On the basis of the control group, Baofukang suppository was used for the combination alternation treatment, and the clinical indexes of the two groups were compared. Results: The control group after treatment, the HPV negative conversion rate was significantly lower than the experimental group, and P <0.05, there are statistically significant differences exist. Conclusion: The combination of Baofukang suppository and recombinant human interferon α-2b gel in patients with cervicitis and HPV infection can achieve more significant effects and is recommended to be popularized.